Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $815 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly and Co (LLY) and maintained a price target of $815.

April 01, 2024 | 12:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald reaffirms an Overweight rating on Eli Lilly and Co, with a price target of $815.
The reiteration of an Overweight rating and a high price target of $815 by a reputable analyst like Louise Chen from Cantor Fitzgerald is likely to instill confidence among investors and could lead to a positive short term impact on Eli Lilly's stock price. The analyst's endorsement serves as a strong signal of the company's potential for growth and profitability, which can attract more investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100